Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.1335 | 1 | 0.5 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0327 | 0.1424 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.1335 | 1 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0371 | 0.1805 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0173 | 0.012 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1335 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0173 | 0.012 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0173 | 0.012 | 0.5 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0402 | 0.2066 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0274 | 0.0973 | 0.5392 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.1335 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0173 | 0.012 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.1335 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0173 | 0.012 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1335 | 1 | 0.5 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0402 | 0.2066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0402 | 0.2066 | 1 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0296 | 0.1163 | 0.8166 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.1335 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.